Cardiogenic shock occurs when the heart is unable to supply enough blood to the vital organs of the body. As a result of the failure of the heart to pump enough nutrients to the body, blood pressure ...

Cardiogenic shock (CS) can happen with advanced heart failure – when your heart can’t pump enough blood to meet your body’s needs. It’s a potentially deadly medical emergency, and you’ll need ...

Cardiogenic shock is characterized by acute hypoperfusion and end-organ dysfunction owing to reduced cardiac output, and is commonly caused by acute myocardial infarction (AMI) with left ventricular ...

Ischemic cardiogenic shock is a complex, self-perpetuating pathological process that frequently causes death irrespective of medical therapy. Early definition of coronary anatomy is a pivotal step ...

Most people who've had a heart attack-or who fear having one-focus on surviving the cardiovascular event itself. But what happens in the hours and days after can be just as critical. One serious ...

Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the ...

More than a quarter of patients with early-stage cardiogenic shock had to be transferred to a higher level of care, progressed to a worse stage of shock, or died, according to a study in six US ...

TAVR is feasible and associated with high success rates in patients with severe aortic stenosis who present with acute cardiogenic shock, but mortality remains much higher in this group than in the ...

A head-to-head comparison of inotropes in the setting of cardiogenic shock revealed no clear victor, with milrinone and dobutamine providing similar outcomes in the randomized DOREMI trial. A ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the 1970s; ...